Diagnostic Accuracy of Multitarget Stool DNA Test for Colorectal Cancer Screening and Detecting in Thailand
- PMID: 39471034
- PMCID: PMC11711336
- DOI: 10.31557/APJCP.2024.25.10.3661
Diagnostic Accuracy of Multitarget Stool DNA Test for Colorectal Cancer Screening and Detecting in Thailand
Abstract
Background: A multitarget stool DNA test offers high sensitivity and specificity for screening and detecting colorectal cancer (CRC) in Western populations. However, its accuracy in Asian people is not well known. This study aimed to examine the diagnostic performance of multitarget stool DNA tests in Thailand.
Methods: A prospective cross-sectional study was conducted from January 2023 to November 2023 at a tertiary university hospital in Bangkok. The study included both asymptomatic and symptomatic patients who underwent stool DNA testing followed by colonoscopy. The multitarget stool DNA test targeted methylation statuses of SDC2, ADHFE1, and PPP2R5C genes. Sensitivity, specificity, and other diagnostic parameters were analyzed.
Results: A total of 274 patients (mean age 62.1 years, 60.6% female) were enrolled. CRC was diagnosed in 17.2% of participants and 6.2% had advanced adenomas. The multitarget stool DNA test demonstrated a sensitivity of 91.5% (95% CI: 79.6-97.6) and specificity of 90.3% (95% CI: 85.7-93.8) for CRC detection. Its sensitivity for detecting CRC did not differ between right-sided lesions (92.3%) and left-sided lesions (91.2%) (P=0.901). The sensitivity for detecting CRC lesions size less than 2 cm was significantly lower than for larger lesions (25% vs 91.7%, p<0.001). Notably, the test's sensitivity and specificity for advanced colorectal neoplasms/cancer were 75.0% (95% CI: 62.6-85.0) and 91.9% (95% CI: 87.4-95.2), respectively.
Conclusions: Multitarget stool DNA testing is highly sensitive and specific for CRC detection in Thai individuals. This testing could represent as a viable non-invasive alternative to colonoscopy especially in settings where colonoscopy is less accessible or less accepted by patients.
Keywords: Screening; Thailand; accuracy; colorectal cancer; multitarget stool DNA test.
Conflict of interest statement
All authors declare that they have no conflict of interest.
Similar articles
-
Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.Clin Epigenetics. 2019 Mar 15;11(1):51. doi: 10.1186/s13148-019-0642-0. Clin Epigenetics. 2019. PMID: 30876480 Free PMC article. Clinical Trial.
-
A Stool DNA-Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population: A Multicenter Prospective Randomized Trial.Am J Gastroenterol. 2025 Mar 1;120(3):614-622. doi: 10.14309/ajg.0000000000003044. Epub 2024 Aug 21. Am J Gastroenterol. 2025. PMID: 39292188 Clinical Trial.
-
Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening.J Cancer Res Clin Oncol. 2023 Sep;149(12):10241-10253. doi: 10.1007/s00432-023-04943-4. Epub 2023 Jun 3. J Cancer Res Clin Oncol. 2023. PMID: 37270460 Free PMC article.
-
Stool DNA methylation assays in colorectal cancer screening.World J Gastroenterol. 2015 Sep 21;21(35):10057-61. doi: 10.3748/wjg.v21.i35.10057. World J Gastroenterol. 2015. PMID: 26401070 Free PMC article. Review.
-
Diagnostic accuracy of multitarget stool DNA testing for colorectal cancer screening: A systematic review and meta-analysis.Gastroenterol Hepatol. 2022 Dec;45(10):753-766. doi: 10.1016/j.gastrohep.2022.01.007. Epub 2022 Jan 31. Gastroenterol Hepatol. 2022. PMID: 35101601 English, Spanish.
Cited by
-
Diagnostic value of genetic and epigenetic biomarker panels for colorectal cancer detection: a systematic review.Int J Colorectal Dis. 2025 May 22;40(1):125. doi: 10.1007/s00384-025-04904-y. Int J Colorectal Dis. 2025. PMID: 40402271 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. - PubMed
-
- Hassan C, Giorgi Rossi P, Camilloni L, Rex DK, Jimenez-Cendales B, Ferroni E, et al. Meta-analysis: Adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test. Aliment Pharmacol Ther. 2012;36(10):929–40. - PubMed
-
- Saito H. Issues in colorectal cancer screening in the asian pacific area. Asian Pac J Cancer Prev. 2000;1(1):77–83. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
